Search our suppliers catalog
Empire Genomics
Empire Genomics
News about Empire Genomics
Break Apart FISH Probes
Break-apart probes are designed to detect translocations, the most common genetic abnormality exhibited in cancer cells. With new gene rearrangements being continuously discovered, and their oncogenic effects elucidated, translocations have become essential cancer biomarkers.
Empire's dual-colored break-apart FISH probes have helped thousands of researchers quickly and reliably track gene translocations. They are designed to flank either side of a gene, so that in the event of a translocation, the two colors will split. Each kit contains 20 tests and normally ships within 1-3 weeks. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads. These products are for research use only (RUO) and are not for use in diagnostic procedures.
View popular Break-Apart Probes
Break-apart probes are designed to detect translocations, the most common genetic abnormality exhibited in cancer cells. With new gene rearrangements being continuously discovered, and their oncogenic effects elucidated, translocations have become essential cancer biomarkers.
Empire's dual-colored break-apart FISH probes have helped thousands of researchers quickly and reliably track gene translocations. They are designed to flank either side of a gene, so that in the event of a translocation, the two colors will split. Each kit contains 20 tests and normally ships within 1-3 weeks. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads. These products are for research use only (RUO) and are not for use in diagnostic procedures.
View popular Break-Apart Probes
Info Empire Genomics
FISH, CISH and other molecular probes.
Empire Genomics designs, manufactures and distributes more than one million clinical and custom labeled molecular probes, enabling hundreds of leading global clinical laboratories, biotechnology organizations and academic institutions to advance biomarker research, accelerate diagnoses and improve personalized treatment options for patients battling cancer and other complex diseases. The company was founded in 2006 by Norma J. Nowak, PhD, a prominent member of the Human Genome Project, to utilize innovative research started at the prestigious Roswell Park Cancer Institute in Buffalo, New York. The comprehensive product portfolio inlcudes Fluorescence in Situ Hybridication (FISH) and Chromogenic in Situ Hybridization (CISH) probes that are designed and optimized for specific diseases, genes, and/or regions across the entire human or mouse genomes.
Empire Genomics designs, manufactures and distributes more than one million clinical and custom labeled molecular probes, enabling hundreds of leading global clinical laboratories, biotechnology organizations and academic institutions to advance biomarker research, accelerate diagnoses and improve personalized treatment options for patients battling cancer and other complex diseases. The company was founded in 2006 by Norma J. Nowak, PhD, a prominent member of the Human Genome Project, to utilize innovative research started at the prestigious Roswell Park Cancer Institute in Buffalo, New York. The comprehensive product portfolio inlcudes Fluorescence in Situ Hybridication (FISH) and Chromogenic in Situ Hybridization (CISH) probes that are designed and optimized for specific diseases, genes, and/or regions across the entire human or mouse genomes.
Currently there are no products of the brand Empire Genomics in our catalog.